Literature DB >> 17100709

Wound complications following kidney and liver transplantation.

A Mehrabi1, H Fonouni, M Wente, M Sadeghi, C Eisenbach, J Encke, B M Schmied, M Libicher, M Zeier, J Weitz, M W Büchler, J Schmidt.   

Abstract

Advances in surgical techniques and immunosuppression (IS) have led to an appreciable reduction in postoperative complications following transplantation. However, wound complications as probably the most common type of post-transplantation surgical complication can still limit these improved outcomes and result in prolonged hospitalization, hospital readmission, and reoperation, consequently increasing overall transplant cost. Our aim was to review the literature to delineate the evidence-based risk factors for wound complications following kidney and liver transplantation (KTx, LTx), and to present the preventive and therapeutic modalities for this bothersome morbidity. Generally, wound complications are categorized as superficial and deep wound dehiscences, perigraft fluid collections and seroma, superficial and deep wound infections, cellulitis, lymphocele and wound drainage. The results of several studies showed that the most important risk factors for wound complications are IS and obesity. Additionally, there are surgical and/or technical factors, including type of incision, reoperation, and surgeon's expertise, as well as comorbidities such as advanced age, diabetes mellitus, malnutrition, and uremia. Preventive management of wound complications necessitates defining their etiological factors so that their detrimental effects on healing processes can be addressed and reduced. IS modalities and agents, especially sirolimus (SRL), and steroids (ST) should be adjusted according to the patient's co-existing risk factors. SRL should be administered three months after transplantation and ST should be tapered as soon as possible. A body mass index (BMI) lower than 30 kg/m2 is advisable for inclusion in a transplantation program, but higher BMIs do not exclude recipients. Surgical risk factors can be prevented by applying precise surgical techniques. Therapeutic modalities must focus on the most efficient and cost-effective medications and/or interventions to facilitate and improve wound healing.

Entities:  

Mesh:

Year:  2006        PMID: 17100709     DOI: 10.1111/j.1399-0012.2006.00608.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  21 in total

1.  Artificial urinary sphincter erosion: the role of corticosteroids in an unusual presentation.

Authors:  Stanley A Yap; Anthony R Stone
Journal:  Can Urol Assoc J       Date:  2010-10       Impact factor: 1.862

Review 2.  [Multimodal oncological therapy concepts, chemotherapy and immunosuppressive drugs: effects on surgical morbidity and mortality].

Authors:  A K Berger; D Jäger
Journal:  Chirurg       Date:  2013-11       Impact factor: 0.955

3.  Vacuum-assisted wound closure and liver transplantation: new perspective and challenges.

Authors:  Daniele Dondossola; Barbara Antonelli; Giorgio Rossi
Journal:  Updates Surg       Date:  2019-11-06

4.  Delayed and short course of rapamycin prevents organ rejection after allogeneic liver transplantation in rats.

Authors:  Salim Hamdani; Allan Thiolat; Sina Naserian; Cynthia Grondin; Stéphane Moutereau; Anne Hulin; Julien Calderaro; Philippe Grimbert; José Laurent Cohen; Daniel Azoulay; Caroline Pilon
Journal:  World J Gastroenterol       Date:  2017-10-14       Impact factor: 5.742

5.  Impaired lower extremity wound healing secondary to sirolimus after kidney transplantation.

Authors:  J George Devries; Rachel C Collier; Jeffrey A Niezgoda; Shawn Sanicola; John P Simanonok
Journal:  J Am Col Certif Wound Spec       Date:  2009-06-23

6.  Wound Healing Complications in Kidney Transplant Recipients Receiving Everolimus.

Authors:  Priscilla Ueno; Claudia Felipe; Alexandra Ferreira; Marina Cristelli; Laila Viana; Juliana Mansur; Geovana Basso; Pedro Hannun; Wilson Aguiar; Helio Tedesco Silva; Jose Medina-Pestana
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

7.  Inconsistencies in the association of clinical factors with the choice of early steroid withdrawal across kidney transplant centers: A national registry study.

Authors:  Sunjae Bae; Jacqueline M Garonzik-Wang; Allan B Massie; Mara A McAdams-DeMarco; Josef Coresh; Dorry L Segev
Journal:  Clin Transplant       Date:  2020-12-12       Impact factor: 2.863

8.  Skin and soft tissue infections in the transplant population.

Authors:  Camille Nelson Kotton
Journal:  Curr Infect Dis Rep       Date:  2008-09       Impact factor: 3.663

9.  Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial.

Authors:  P De Simone; F Nevens; L De Carlis; H J Metselaar; S Beckebaum; F Saliba; S Jonas; D Sudan; J Fung; L Fischer; C Duvoux; K D Chavin; B Koneru; M A Huang; W C Chapman; D Foltys; S Witte; H Jiang; J M Hexham; G Junge
Journal:  Am J Transplant       Date:  2012-08-06       Impact factor: 8.086

10.  Relationship between Post-kidney Transplantation Antithymocyte Globulin Therapy and Wound Healing Complications.

Authors:  G R Pourmand; S Dehghani; A Saraji; S Khaki; S H Mortazavi; A Mehrsai; H Sajadi
Journal:  Int J Organ Transplant Med       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.